Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer.

Int J Mol Sci · 2023 · PMC10053938 · PMID 36982561

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

After the milestone publication of the MAGIC trial in 2006, a positive trend of prolonged survival was observed in locally advanced GC patients undergoing neoadjuvant chemotherapy (NACT), and several clinical trials also confirmed these results recently [ 2 , 3 , 4 , 5 ].

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.